Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Rheumatic Diseases | 6 | 2021 | 2675 | 0.83 | Why? |
| Rheumatologists | 1 | 2020 | 346 | 0.64 | Why? |
| Musculoskeletal Diseases | 3 | 2021 | 646 | 0.39 | Why? |
| Periodicals as Topic | 1 | 2020 | 1492 | 0.33 | Why? |
| Antirheumatic Agents | 2 | 2020 | 3023 | 0.31 | Why? |
| Clinical Competence | 1 | 2020 | 3263 | 0.29 | Why? |
| Rheumatology | 4 | 2021 | 1213 | 0.26 | Why? |
| Psoriasis | 3 | 2021 | 1739 | 0.22 | Why? |
| Internal Medicine | 2 | 2017 | 557 | 0.22 | Why? |
| Organizations, Nonprofit | 1 | 2020 | 87 | 0.20 | Why? |
| Patient Handoff | 1 | 2017 | 68 | 0.16 | Why? |
| Professionalism | 1 | 2017 | 171 | 0.14 | Why? |
| Immunotherapy | 2 | 2018 | 2421 | 0.14 | Why? |
| Immunosuppressive Agents | 2 | 2020 | 6331 | 0.11 | Why? |
| Graft Rejection | 1 | 2020 | 1766 | 0.10 | Why? |
| Learning | 1 | 2017 | 1181 | 0.09 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 896 | 0.09 | Why? |
| Immunologic Factors | 2 | 2021 | 4206 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2020 | 1996 | 0.08 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.08 | Why? |
| Delphi Technique | 2 | 2021 | 1257 | 0.08 | Why? |
| Internship and Residency | 2 | 2017 | 4987 | 0.08 | Why? |
| Organ Transplantation | 1 | 2020 | 2616 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Advisory Committees | 2 | 2021 | 1418 | 0.06 | Why? |
| Curriculum | 1 | 2017 | 3083 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2020 | 9335 | 0.06 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.05 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.05 | Why? |
| Practice Guidelines as Topic | 2 | 2021 | 15421 | 0.05 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.05 | Why? |
| Epidemiology | 1 | 2020 | 216 | 0.04 | Why? |
| Academies and Institutes | 1 | 2021 | 539 | 0.04 | Why? |
| Infectious Disease Medicine | 1 | 2020 | 311 | 0.04 | Why? |
| Sarcoidosis | 1 | 2020 | 271 | 0.04 | Why? |
| Education, Distance | 1 | 2017 | 4956 | 0.04 | Why? |
| Consensus | 2 | 2021 | 6345 | 0.04 | Why? |
| Biological Products | 2 | 2021 | 2331 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Janus Kinase Inhibitors | 1 | 2020 | 682 | 0.03 | Why? |
| Models, Educational | 1 | 2017 | 289 | 0.03 | Why? |
| Humans | 13 | 2021 | 930598 | 0.03 | Why? |
| United States | 4 | 2021 | 46150 | 0.03 | Why? |
| Immunomodulation | 1 | 2020 | 1472 | 0.03 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.02 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2021 | 3228 | 0.02 | Why? |
| Arthritis, Rheumatoid | 1 | 2020 | 2043 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.02 | Why? |
| Dermatology | 1 | 2020 | 1999 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| Transplant Recipients | 1 | 2020 | 4982 | 0.02 | Why? |
| Inflammatory Bowel Diseases | 1 | 2020 | 3209 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| Aged | 3 | 2020 | 215776 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Male | 3 | 2020 | 367725 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Middle Aged | 2 | 2020 | 270681 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Female | 2 | 2020 | 380317 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Adult | 1 | 2020 | 244371 | 0.00 | Why? |
Calabrese's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(75)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(92)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_